Clinical Trial Update: Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients [Phase 4]

View source ↗

Summary

Phase 4 study evaluating simplification of a single-tablet HIV regimen has been completed. Sponsor: Gilead Sciences.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 4 | Status: COMPLETED